Global Oligonucleotide Synthesis Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024
Report Type : Global

Share This On

Home > Reports > Biotechnology > Agriculture > Global Oligonucleotide Synthesis Market – Size, Outlook, Trends and Forecast (2024 – 2032)
CHAPTER 1. INTRODUCTION

    1.1. Market Definition

    1.2. Executive Summary

    1.3. The Scope of the Study

CHAPTER 2. RESEARCH METHODOLOGY

    2.1. Secondary Research

    2.2. Primary Research

    2.3. Analytic Tools and Model

    2.4. Economic Indicator

            2.4.1 Base Year, Base Currency, Forecasting Period

    2.5. Expert Validation

    2.6. Study Timeline

CHAPTER 3. MARKET ANALYSIS

    3.1. Industry Value Chain Analysis

    3.2. Porter's Five Force Analysis

            3.2.1. Bargaining Power of Buyers

            3.2.2. Bargaining Power of Suppliers

            3.2.3. Threats of Substitutes

            3.2.4. Threats of New Entrants

            3.2.5. Degree of Competition

    3.3. PESTLE Analysis

            3.3.1. Political

            3.3.2. Economical

            3.3.3. Social

            3.3.4. Technological

            3.3.5. Legal

            3.3.6. Environmental

    3.4. SWOT Analysis

            3.4.1. Strengths

            3.4.2. Weakness

            3.4.3. Opportunities

            3.4.4. Threats

    3.5. Y-O-Y Analysis

CHAPTER 4. MARKET DYNAMICS

    4.1. Market Drivers

            4.1.1. The rise in venture capital investments

            4.1.2. Increase in government investments and R&D

            4.1.3. Growing use of synthesised oligonucleotides in molecular diagnostic’s

    4.2. Market Restraints & Challenges

            4.2.1. Large-scale synthesis of oligonucleotides

            4.2.2. Price erosion of synthesised oligonucleotides

    4.3. Market Opportunities

            4.3.1. Emerging economies

CHAPTER 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET – BY

PRODUCT

    5.1. Introduction

    5.2. Synthesized Oligonucleotides

            5.2.1. By Type

            5.2.2.1. Custom Oligonucleotides

            5.2.2.2. Pre-Designed Oligonucleotides

            5.2.2. By Product

            5.2.1.1. Primers

            5.2.1.2. Probes

            5.2.1.3. Large-Scale Synthesis Oligonucleotides

            5.2.1.4. Intermediate-Scale Synthesis Oligonucleotides

            5.2.1.5. Linkers & Adaptors

    5.3. Reagents

    5.4. Equipment

CHAPTER 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET – BY

APPLICATION

    6.1. Introduction

    6.2. Diagnostics

    6.3. Therapeutics

            6.3.1. RNAi

            6.3.2. Nucleic Acid Aptamers

            6.3.3. DNA/Antisense Oligonucleotides

            6.3.4. Immunotherapy Applications

    6.4. Research

            6.4.1. PCR

            6.4.2. QPCR

            6.4.3. Sequencing

            6.4.4. Gene Synthesis

            6.4.5. Other Research Applications

CHAPTER 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET – BY END

USER

    7.1. Introduction

    7.2. Diagnostic Laboratories

    7.3. Pharmaceutical and Biotechnology Companies

    7.4. Academic Research Institutes

    7.5. Other End Users

CHAPTER 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - BY

GEOGRAPHY

    8.1. Introduction

    8.2. North America

            8.2.1. U.S.

            8.2.2. Canada

            8.2.3. Mexico

            8.2.4. Costa Rica

    8.3. South America

            8.3.1. Brazil

            8.3.2. Argentina

            8.3.3. Chile

            8.3.4. Columbia

            8.3.5. Others

    8.4. Europe

            8.4.1. U.K.

            8.4.2. Germany

            8.4.3. France

            8.4.4. Italy

            8.4.5. Spain

            8.4.6. Russia

            8.4.7. Netherlands

            8.4.8. Switzerland

            8.4.9. Poland

            8.4.10. Others

    8.5. APAC

            8.5.1. China

            8.5.2. Japan

            8.5.3. India

            8.5.4. South Korea

            8.5.5. Australia & New Zealand

            8.5.6. Malaysia

            8.5.7. Singapore

            8.5.8. Others

    8.6. Middle East & Africa

            8.6.1. UAE

            8.6.2. Saudi Arabia

            8.6.3. Iran

            8.6.4. Iraq

            8.6.5. Qatar

            8.6.6. South Africa

            8.6.7. Algeria

            8.6.8. Morocco

            8.6.9. Nigeria

            8.6.10. Egypt

            8.6.11. Others

CHAPTER 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET - COMPANY

PROFILES

    9.1.  Integrated DNA Technologies

    9.2.  Merck KGaA

    9.3.  Eurofins Genomics

    9.4.  Thermo Fisher Scientific

    9.5.  Bioautomation Corporation

    9.6.  Agilent Technologies

    9.7.  Eurogentec

    9.8.  GE Healthcare

    9.9.  LGC Biosearch Technologies

    9.10. Nitto Denko Avecia Inc

    9.11. Genscript Corporation

    9.12. Genedesign (Part of Ajinomoto)

    9.13. TriLink Biotechnologies, Inc

    9.14. Bio-Synthesis

    9.15. ATDBio Ltd

CHAPTER 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET -

COMPETITIVE LANDSCAPE

    10.1. Market Share Analysis

    10.2. Strategies adopted by top companies

    10.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 11. MARKET INSIGHTS

    11.1. Industry Experts Insights

    11.2. Analysts Opinions

    11.3. Investment Opportunities

CHAPTER 12. APPENDIX

    12.1. List of Tables

    12.2. List of Figures

Other Reports

Global Sesame Seeds Market – Size, Outlook, Trends and...

Starting from $2700

Global Meat Ingredients Market – Growth, Trends And...

Starting from $2700

Unmanned Aerial Vehicle Drones Market – Size, Outlook,...

Starting from $2700

Stay in the loop

Keep up-to-date with our weekly newsletter, Media Pulse.

Data-driven market insights & solutions

Follow Us On

We Accept

Our Office

30 N Gould St Ste N Sheridan,
WY 82801

© 2025 - Envision Intelligence | All Rights Reserved.
Designed by Webixion